ArticleJournal of mood and anxiety disorders2025
Validation of modified COVID-19 Phobia Scale (MC19P-SE) to examine the relationships between corona anxiety and COVID-19 symptoms: A case-control study.
Article in Journal of mood and anxiety disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The main purpose of the present study is to validate the modified COVID-19 phobia scale (MC19P-SE) in Bangla and use it to identify the link between COVID-related anxiety and the onset of COVID-19 symptoms. Methods: A retrospective case-control study was conducted in Sylhet, a northeastern district in Bangladesh, focusing on a population of 18 years or older. The MC19P-SE scale was used to gather data on coronaphobia among the respondents, and factor analysis was used to derive reliable factors. We employed a multivariable logistic regression model to identify the relationships between coronavirus anxiety and COVID-19 symptoms. Results: Among the 482 participants, 42 % manifested COVID-19 symptoms. Factor analysis revealed four underlying factors: psychological anxiety, psychosomatic anxiety, economic anxiety, and social or excessive protective anxiety. MC19P-SE exhibited reliability with a Cronbach alpha coefficient of 0.91 for full-scale. According to the model, psychosomatic anxiety increased (AOR= 1.14, 95 % CI: 1.07, 1.22) the risk while social or excessive protective anxiety decreased (AOR=0.88, 95 % CI: 0.78, 0.99) the risk of developing COVID-19 symptoms significantly. Conclusion: The research found a significant relation in the Bangladeshi district of Sylhet between the onset of COVID-19 symptoms and anxiety associated with the virus. Furthermore, the findings affirm the potential reliability and validity of the MC19P-SE scale, strengthening its efficacy for future research and evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.